Ertapenem Versus Piperacillin/Tazobactam in the Treatment of Complicated Intraabdominal Infections: Results of a Double-Blind, Randomized Comparative Phase III Trial

OBJECTIVE: To examine the clinical efficacy and safety of ertapenem, a novel β-lactam agent with wide activity against common pathogens encountered in intraabdominal infection. SUMMARY BACKGROUND DATA: Ertapenem has a pharmacokinetic profile and antimicrobial spectrum that support the potential for...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Solomkin, Joseph S., Yellin, Albert E., Rotstein, Ori D., Christou, Nicolas V., Dellinger, E. Patchen, Tellado, Jose M., Malafaia, Osvaldo, Fernandez, Alvaro, Choe, Kyuran A., Carides, Alexandra, Satishchandran, Vilas, Teppler, Hedy
Формат: Artigo
Язык:Inglês
Опубликовано: 2003
Предметы:
Original Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC1522141/
https://ncbi.nlm.nih.gov/pubmed/12560782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.SLA.0000048551.32606.73
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы